Single Cohort, 2-Period Study to Assess Pharmacokinetics of Metformin Alone and in Combination With Ranolazine 500 mg
Status:
Completed
Trial end date:
2012-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effect of steady-state ranolazine 500 mg bid on
the steady state pharmacokinetics (PK) of metformin in subjects with type 2 diabetes mellitus
(T2DM).